Literature DB >> 28177519

Methionine 35 sulphoxide reduces toxicity of Aβ in red blood cell.

Cristiana Carelli-Alinovi1, Francesco Misiti2.   

Abstract

BACKGROUND: The oxidation of methionine residue in position 35 of Ab to sulphoxide (Ab-sulphoxide) has the ability to deeply modify wild-type Ab 1-42 (Ab) neurotoxic action. Our previous studies suggest that in nucleated cells, lower toxicity of Ab-sulphoxide might result not from structural alteration, but from elevation of methionine sulphoxide reductase A (MsrA) activity and mRNA levels.
DESIGN: On this basis, we hypothesised that red blood cell (RBC), a cell devoid almost completely of MsrA activity, shares with nucleated cells an antioxidant system induced by methionine 35 sulphoxide, responsible for the lower toxicity of Ab-sulphoxide in RBC. (Results) Supporting this hypothesis, we found that the low toxicity of Ab-sulphoxide in RBC correlated with pentose phosphate pathway (PPP) flux increase, and this event was associated with a low level of methionine oxidation in total proteins. None of these effects were observed when cells were exposed to Ab native. DISCUSSION: These results outline the importance of the redox state of methionine 35 in the modulation of Ab-mediated events and suggest an important protective role for PPP in RBC of patients affected by Alzheimer's disease.
© 2017 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  Alzheimer's disease; amyloid beta-peptide (1-42); caspase 3; methionine 35; oxidative stress; pentose phosphate pathway; red blood cell

Mesh:

Substances:

Year:  2017        PMID: 28177519     DOI: 10.1111/eci.12735

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  1 in total

1.  Cold Atmospheric Plasma Modification of Amyloid β.

Authors:  Maho Yagi-Utsumi; Tomohiro Tanaka; Yoko Otsubo; Akira Yamashita; Shinji Yoshimura; Motohiro Nishida; Koichi Kato
Journal:  Int J Mol Sci       Date:  2021-03-18       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.